Expert Insights-GoBroad Healthcare Group

中文 English Pусский العربية

Prof. Dingwei Ye: How China’s Prostate Cancer Guidelines Are Advancing Precision and Long-Term Care

2026-9-30
View
Dr. Yajing Zhang’s Team: Rethinking Sequential CAR-T in Extramedullary Myeloma — From Target Selection to Dynamic Disease Profiling

2026-9-24
View
Dr. Haifeng Qin: Tarlatamab Is Reshaping SCLC Treatment as Research-Oriented Hospitals Accelerate Clinical Translation

2026-9-2
View
Dr. Jing Pan: Novel Nanobody-Based Biparatopic CD5 CAR-T Accelerates Expansion and Redefines Immunotherapy for Relapsed/Refractory T-ALL

2026-6-26
View
Professor Chunfu Li’s Team: Nearly 500 Cases in 5 Years — TDH Transplantation Achieves Low GVHD, Rapid Immune Reconstitution, and Reduced Relapse

2026-4-14
View
Dr. Yajing Zhang: Exploring the Frontiers and Enhancing Synergy — Multidimensional Innovation and Strategic Perspectives in CAR-T Therapy

2025-12-29
View
Dr. Kai Hu: Multiple Advances in CAR-T Cell Therapy for Relapsed/Refractory Lymphoma

2025-12-29
View
Dr. Zhihui Li: How Genetic Predisposition Genes Are Reshaping Donor Selection Strategies in Allogeneic Hematopoietic Stem Cell Transplantation

2025-12-29
View
Dr. Huaying Liu: Focusing on CAR-T–Bridged Transplantation and Novel Anti-Relapse Strategies with “Passenger Cord Blood”

2025-12-29
View

Remote Second Opinion